Benzinga All Access

A "Gig Enabled" Workforce – This Company Is Helping Connect Gig Workers With Brick And Mortar Shift Work

New Regulations May Be Coming To Combat Dangerous "Forever Chemicals" – This Cleantech Innovator Is Ready

Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA

New Regulations May Be Coming To Combat Dangerous "Forever Chemicals" – This Cleantech Innovator Is Ready

Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA

2023 Was A Big Year For ESE Entertainment, What Does 2024 Hold?

This Bitcoin Miner Also Provides High-End Computing For Large Language Models

2023 Was A Big Year For ESE Entertainment, What Does 2024 Hold?

This Bitcoin Miner Also Provides High-End Computing For Large Language Models

This BioPharma Could Be First To Market With Its Celiac Therapy – Phase 3 Clinical Trials To Commence In 2024

CEO Of Canada's Largest Regulated Digital Asset Player Talks BTC ETF And The Future Of ETH

Benzinga All Access Recent News

Are You Trading Too Much? Hear From This Long Time Trading Expert

Martha Stokes, CMT, Co-founder & CEO of TechniTrader was a guest recently on Benzinga’s All-Access.

Cleantech Innovator BioLargo Lands First PFAS Removal Client

Dennis Calvert, President & CEO of BioLargo Inc. (OTCQB: BLGO) was recently a guest on Benzinga’s All-Access.

This Battery Maker Continues To Grow Sales Of New RV Power Unit

Denis Phares, CEO of Dragonfly Energy Holdings Corp. (NASDAQ: DFLI), was recently a guest on Benzinga.

This ETF Provider Knows Commodities – Hear From A Senior Portfolio Manager

Jake Hanley, Managing Director & Sr. Portfolio Strategist for Teucrium ETFs, was recently a guest on Benzinga’s All-Access.

This Innovator Reports Successfully Commercializing Electro-Optic Polymers, Validating The Technology

Dr. Michael Lebby, Chairman and CEO of Lightwave Logic, Inc. (NASDAQ: LWLG), was recently a guest on Benzinga’s All-Access.

Beverage Marketing Leader Shares What It Takes To Make A Product And Brand Stand Out In A Crowded Market

Sean Dollinger, CEO of LQR House (NASDAQ: LQR), was recently a guest on Benzinga’s All-Access.

Plant-Based Clean Nutrition For Early Life – What Are You Feeding Your Baby?

Hamutal Yitzhak, Co-Founder and CEO of Else Nutrition (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) was recently a guest on Benzinga’s All-Access.

TechniTrader CEO Shares Trading Insights – Moving Beyond "Retail Advice" With This Educational Company

Martha Stokes, CMT, Co-founder & CEO of TechniTrader was a guest recently on Benzinga’s All-Access.

Taking The Berkshire Hathaway Approach, This Company That Began As A Minerals Firm Is Taking A New Path

Brian Esposito, CEO of Diamond Lake Minerals, Inc. (OTCMKTS: DLMI), was recently a guest on Benzinga’s All-Access.

Biotech Takes Innovative Approach To Raising Capital For Its Promising Anti-Cancer Drug

Dr. Vuong Trieu, CEO & Chairman of Oncotelic Therapeutics, Inc. was recently a guest on Benzinga’s All-Access. Oncotelic is a biotechnology company focused on developing RNA therapeutics for hard-to-treat cancers. The company has extensive experience in the field and its lead candidate OT-101 has shown very positive results in trials.

It's Not Just Retail Car Purchases, EVs Stand To Revolutionize The Industrial Space Too

Raymond Wang, CEO of Greenland Technologies Holding Corp. (NASDAQ: GTEC), was recently a guest on Benzinga’s All-Access.

How Artificial Intelligence Platform BullFrog AI Aims To Advance Drug Research By Leaps And Bounds

Vin Singh, Founder & CEO of BullFrog AI (NASDAQ: BFRG), was recently a guest on Benzinga’s All-Access.

Canada's Largest Cryptocurrency Player Offers Cryptocurrency Payment Processing On A Global Scale

Dean Skurka, CEO of WonderFi Technologies Inc (TSX: WNDR) (OTCQB: WONDF) (WKN: A3C166), was recently interviewed by Benzinga.

Trading Expert Shares Insights Into How To Find Success In The Market

Martha Stokes, CMT, Co-founder & CEO of TechniTrader, was recently a guest on Benzinga’s All-Access.

Small Modular Nuclear Reactors – Are They The Future of Energy?

J. Clay Sell, CEO of X-Energy Reactor Company, was recently a guest on Benzinga’s All-Access.

Innovative Smart Home Gym Makes Push Into MultiFamily With New Deal

Trent Ward, CEO of Interactive Strength doing business as FORME (NASDAQ: TRNR), was a guest recently on Benzinga’s All-Access.

Does Bone Marrow Contain The Keys To Curing Alzheimer's? BioTech Announces Promising Results From Clinical Trial

Wa’el Hashad, CEO of Longeveron (NASDAQ: LGVN), was a guest recently on Benzinga’s All-Access.

Peyote May Be The Next Big Thing In Mental Health, And This Company Is Canada's Largest Producer

Claire Stawnyczy, CEO of Lophos Pharmaceuticals (CSE: MESC), was a guest recently on Benzinga’s All-Access.

With All The Hype Surrounding Companies Like Tesla And Rivian, Industrial EVs Could Be The Unsung Heros For Investors – Meet This Promising Contender

Raymond Wang, CEO of Greenland Technologies Holdings (NASDAQ: GTEC), was recently a guest on Benzinga’s All-Access.

Benzinga's Luke Jacobi Hosts Special All Access, Talks With CEO Of This Thriving E-Comm Business

David Meniane, CEO of CarParts.com (NASDAQ: PRTS), was a guest recently on a special edition of All-Access hosted by Benzinga’s own, Luke Jacobi.

Keys To Success As A Trader - Moving Beyond "Retail Advice" With This Educational Company

Martha Stokes, CMT, Co-founder & CEO of TechniTrader was a guest recently on Benzinga’s All-Access.

RNA Therapies Hold The Power To Transform Treatment For Numerous Ailments, But Delivering These Remains Problematic – Will This Biotech Change That?

Thomas Meyer, CEO of Altamira Therapeutics (NASDAQ: CYTO), was recently a guest on Benzinga’s All-Access.

Innovative Biotech Company Announces Agreement To Perform CBD Pill Clinical Study

Dr. Jim Woody, CEO of 180 Life Sciences Corp. (NASDAQ: ATNF), was recently a guest on Benzinga’s All-Access.